Variable |  | T1D N = 66 |  | Control group N = 30 |  | P |
---|---|---|---|---|---|---|
 | Mean(SD) (min, max) |  | Mean(SD) (min, max) |  | ||
Age [years] | Â | 7.67(4.26)(1.00,15.00) | Â | 8.14(3.27)(2.17,13.25) | Â | 0.557 |
Gender [male %] | Â | 56.7% | Â | 75.8% | Â | 0.059 |
BMI [kg/m2] | Â | 17.76(2.95)(13.06,24.68) | Â | 17.11(1.83)(14.66,22.44) | Â | 0.681 |
T1D duration [years] | Â | 1.57(2.16)(0.04,9.00) | Â | N/A | Â | N/A |
HbA1c [%] |  | 9.63(2.47)(5.60,14.9) |  | 5.05(0.60)(4.10,6.10) |  |  < 0.0001 |
Glucose [mmol/L] |  | 9.40(4.58)(2.92,20.73) |  | 4.71(0.50)(3.9,5.82) |  |  < 0.0001 |
Totalcholesterol [mmol/L] | Â | 4.90(0.91)(2.81,8.17) | Â | 4.91(0.71)(3.86,6.13) | Â | 0.345 |
HDL cholesterol [mmol/L] | Â | 1.39(0.44)(0.33,2.46) | Â | 1.36(0.16(0.94,1.65)) | Â | 0.703 |
LDL cholesterol [mmol/L] | Â | 2.46(0.91)(0.70,4.81) | Â | 2.56(0.74)(0.70,3.75) | Â | 0.771 |
Triglycerides [mmol/L] | Â | 1.17(0.47)(0.40,2.44) | Â | 1.16(0.43)(0.39,1.83) | Â | 0.357 |
TDD [IU/kg] | Â | 0.94(0.23)(0.00,1.42) | Â | N/A | Â | N/A |
Basal insulin dose [%of TDD] | Â | 33.47(16.13)(6.90,100.00) | Â | N/A | Â | N/A |
FGF−19 [pg/mL] |  | 226.52(18.95)(186.82,266.25) |  | 240.08(23.53)(197.20,277.98) |  | 0.03 |
VEGF [pg/mL] | Â | 227.95(48.65)(146.57,376.34) | Â | 205.92(28.27)(132.72,249.33) | Â | 0.016 |
sklotho [pg/mL] | Â | 2448.67(791.92)(1070.87,3923.97) | Â | 3083.55(1113.47)(969.70,5623.69) | Â | 0.011 |